SILVER SPRING, Md., BOSTON and SOUTH SAN FRANCISCO, Calif., May 18 /PRNewswire/ -- The Pulmonary Hypertension Association (PHA), Tufts Medical Center, and Actelion Pharmaceuticals US, Inc., today announced Dr. Nicholas Hill of Tufts Medical Center as the recipient of the 2009 PHA Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care. The grant, in the amount of $50,000, will be awarded to Tufts Medical Center to support continued excellence in care for patients with PAH. The award, supported by an unrestricted educational grant from Actelion, was presented at the 2009 International Conference of the American Thoracic Society (ATS) in San Diego.
"Dr. Hill has dedicated his career to improving the lives of patients with PAH," said Michael McGoon, MD, Professor of Medicine and Consultant in Cardiology at the Mayo Clinic College of Medicine and chair of the Independent Award Selection Committee. "His passionate desire to better the lives of patients, and his consistent excellence in PAH clinical research and medical, epitomize the spirit of the PHA. We are pleased to present this award in recognition of his devotion."
The PHA Award of Excellence in PAH Care is designed to honor and acknowledge healthcare professionals who are committed to improving outcomes for patients with PAH. It is awarded annually to outstanding care providers for clinical practice excellence in the area of PAH.
"The Pulmonary Hypertension Association Award of Excellence encourages advances in both patient care and research in the area of PAH, a serious condition that continues to be under-recognized and under-treated," said Rino Aldrighetti, president of PHA. "In recent years, the picture for patients with PAH has brightened due to improved patient care and treatment options. PHA believes that this annual award - in conjunction with its significant financial support for the recipient's work - shines a spotlight on this diseas
|SOURCE Pulmonary Hypertension Association; Tufts Medical Center; Actelion Pharmaceuticals US, Inc.|
Copyright©2009 PR Newswire.
All rights reserved